Abstract
Chordomas are tumors with a bad prognosis, because of their location, local aggressiveness and high rate of local relapse. Despite of be benign tumors, they have certain capacity of metastasize and a clinical evolution that results interesting. When we analyzed our series with 35 chordomas studied and treated between 1975 and 2002, we found three patients that experienced a systemic dissemination.
Similar content being viewed by others
References
Sundaresan N, Boriani S, Rothman A, Holtzman R (2004) Tumors of the osseous spine. J Neurooncology 69:273–290
Markwalder TM, Regula V, Markwalder RV et al (1979) Metastatic chordoma. Surg Neurol 12: 473–478
Soo MY (2001) Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol 45:427–434
Chetty RC, Levin VC, Kalan MR (1991) Chordoma: a 20-year clinicopathologic review of the experience at Groote Schuur Hospital, Cape Town. J Surg Oncol 46:261–264
Fourney DR, Gokasian ZL (2003) Current management of sacral chordoma. Neurosurg Focus 15(2):E9
McPherson CM, Suki D, McCutcheon IE et al (2006). Metastatic disease from spinal chordoma: a 10-year experience. J Neurosurg Spine 5:277–280
McMaster ML, Goldstein AM, Bromley CM et al (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12(1):1–11
Tai PT, Craighead P, Liem SK et al (2000) Management issues in chordoma: a case series. Clin On col (R Coll Radiol) 12(2):80–86
St. Martin M, Levine SC (2003) Chordomas of the skull base: manifestations and management. Curr Opin Otolaryngol Head Neck Surg 11:324–327
Romero J, Cárdenes H, De la Torre A et al (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32
Catton C, O’sullivan B, Bell R et al (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72
Igaki H, Tokuuye K, Okumura T et al (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60(4):1120–1126
Mendenhall WM, Mendenhall CM, Lewis SB et al (2005) Skull base chordoma. Head Neck 27(2):159–165
Imai R, Kamada T, Tsuji H et al (2004) Carbon ion radiotherapy for unresectable sacral chordoma. Clin Cancer Res 10:5741–5746
Casali PG, Stacchiotti S, Sangalli C et al (2007) Curr Opin Oncol 19:367–370
Jacob HE (1994) Chemotherapy for cranial base tumors. J Neurooncol 20:327–335
Schonegger K, Gelpi E, Prayer D et al (2005) Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progression. Anticancer Drugs 16(10):1139–1143
Fleming GF, Heiman PS, Stephens JK et al (1993) Dedifferentiated chordoma: response to aggressive chemotherapy in two cases. Cancer 72:714–718
Auger M, Raney B, Callender D et al (1994) Metastatic intracranial chordoma in a child with massive pulmonary tumor emboli. Fetal Pediatr Pathol 14:763–770
Casali PG, Messina A, Stracchiotti S et al (2004) Imatinib mesylate in chordoma. Cancer 101: 2086–2097
Hof H, Welzel T, Debus J (2006) Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 29:572–574
Clinical Trial Phase II. Efficacy and Safety of Imatinib in Chordoma, Milano, Italy. Novartis. NCT00150072/CSTI571BIT15
Bergh P, Kindblom LG, Gutenberg B et al (2000) Prognostic factors in chordoma of the sacrum and mobile spine (39 patients). Cancer 88(9):2122–2134
Chambers PW, Schwinn CP (1979) Chordoma. A clinicopathologic study of metastasis. Am J Clin Pa thol 72(5):765–776
St. Delank KS, Kriegsmann J, Drees PH et al (2002) Metastasising chordoma of the lumbar spine. Eur Spine J 11(2):167–171
Higinbotham NL, Phillips RF, Farr HW, Husyu HO (1967) Chordoma. Thirty-five-year study at Memorial Hospital. Cancer 20:1841–1850
Heffelfinger M J, Dahlin DC, MacCarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32:410–420
Asano S, Kawahara N, Kirino T (2003) Case report. Intradural spinal seeding of a clival chordoma. Acta Neurochir 145:599–603
Baratti D, Gronchi A, Pennachioli E et al (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Onco 10:291–296
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vergara, G., Belinchón, B., Valcárcel, F. et al. Metastatic disease from chordoma. Clin Transl Oncol 10, 517–521 (2008). https://doi.org/10.1007/s12094-008-0243-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0243-4